POGGIO, FRANCESCA BENEDETTA

POGGIO, FRANCESCA BENEDETTA  

100007 - Dipartimento di Medicina interna e specialità mediche  

Mostra records
Risultati 1 - 20 di 39 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autore(i) File
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate 1-gen-2021 Poggio, F.; Tagliamento, M.; Ceppi, M.; Bruzzone, M.; Conte, B.; Fregatti, P.; Punie, K.; de Azambuja, E.; Del Mastro, L.; Lambertini, M.
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of Fc gamma RIIIA/Fc gamma RIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 1-gen-2015 Boero, S; Morabito, A; Banelli, B; Cardinali, B; Dozin, B; Lunardi, G; Piccioli, P; Lastraioli, S; Carosio, R; Salvi, S; Levaggi, A; Poggio, F; D'Alonzo, A; Romani, M; Del Mastro, L; Poggi, A; Pistillo, M
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 1-gen-2022 Conte, B.; Montemurro, F.; Levaggi, A.; Blondeaux, E.; Molinelli, C.; Cardinali, B.; Poggio, F.; Buzzatti, G.; Bighin, C.; Lambertini, M.; Del Mastro, L.
Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study 1-gen-2020 Blondeaux, Eva; Ferreira, Arlindo R; Poggio, Francesca; Puglisi, Fabio; Bighin, Claudia; Sottotetti, Federico; Montemurro, Filippo; Poletto, Elena; Lai, Antonella; Sini, Valentina; Minuti, Gabriele; Mura, Silvia; Fontana, Andrea; Fregatti, Piero; Cardinali, Barbara; Lambertini, Matteo; Del Mastro, Lucia
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects 1-gen-2018 Brandão, Mariana; Pondé, Noam F.; Poggio, Francesca; Kotecki, Nuria; Salis, Mauren; Lambertini, Matteo; de Azambuja, Evandro
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 1-gen-2017 Poggio, F.; Ceppi, M.; Lambertini, M.; Bruzzi, P.; Ugolini, D.; Bighin, C.; Levaggi, A.; Giraudi, S.; D'Alonzo, A.; Vaglica, M.; Blondeaux, E.; Sertoli, M. R.; Pronzato, P.; Del Mastro, L.
Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do? 1-gen-2018 Poggio, Francesca; Lambertini, Matteo; de Azambuja, Evandro
Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: (ESMO Open (2021) 6(2), (S2059702921000089), (10.1016/j.esmoop.2021.100054)) 1-gen-2021 De Angelis, C.; Bruzzese, D.; Bernardo, A.; Baldini, E.; Leo, L.; Fabi, A.; Gamucci, T.; De Placido, P.; Poggio, F.; Russo, S.; Forestieri, V.; Lauria, R.; De Santo, I.; Caputo, R.; Cianniello, D.; Michelotti, A.; Del Mastro, L.; De Laurentiis, M.; Giuliano, M.; De Placido, S.; Arpino, G.
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 1-gen-2020 Blondeaux, Eva; Lambertini, Matteo; Michelotti, Andrea; Conte, Benedetta; Benasso, Marco; Dellepiane, Chiara; Bighin, Claudia; Pastorino, Simona; Levaggi, Alessia; D’ Alonzo, Alessia; Poggio, FRANCESCA BENEDETTA; Buzzatti, Giulia; Molinelli, Chiara; Fregatti, Piero; Bertoglio, Sergio; Boccardo, Francesco; DEL MASTRO, Lucia
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 1-gen-2020 Lambertini, Matteo; Poggio, Francesca; Bruzzone, Marco; Conte, Benedetta; Bighin, Claudia; de Azambuja, Evandro; Giuliano, Mario; De Laurentiis, Michele; Cognetti, Francesco; Fabi, Alessandra; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Urracci, Ylenia; Garrone, Ornella; Puglisi, Fabio; Montemurro, Filippo; Ceppi, Marcello; Del Mastro, Lucia
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 1-gen-2020 Conte, B.; Bruzzone, M.; Lambertini, M.; Poggio, F.; Bighin, C.; Blondeaux, E.; De Laurentiis, M.; Valle, E.; Cognetti, F.; Nistico, C.; De Placido, S.; Garrone, O.; Gamucci, T.; Montemurro, F.; Puglisi, F.; Cardinali, B.; Fregatti, P.; Miglietta, L.; Boccardo, F.; Ceppi, M.; Del Mastro, L.
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 1-gen-2021 De Angelis, C; Bruzzese, D; Bernardo, A; Baldini, E; Leo, L; Fabi, A; Gamucci, T; De Placido, P; Poggio, F; Russo, S; Forestieri, V; Lauria, R; De Santo, I; Michelotti, A; Del Mastro, L; De Laurentiis, M; Giuliano, M; De Placido, S; Arpino, G
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 1-gen-2016 Boero, Silvia; Morabito, Anna; Banelli, Barbara; Cardinali, Barbara; Dozin, Beatrice; Lunardi, Gianluigi; Piccioli, Patrizia; Lastraioli, Sonia; Carosio, Roberta; Salvi, Sandra; Levaggi, Alessia; Poggio, Francesca; D'Alonzo, Alessia; Romani, Massimo; Del Mastro, Lucia; Poggi, Alessandro; Pistillo, Maria Pia
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial 1-gen-2021 Del Mastro, Lucia; Mansutti, Mauro; Bisagni, Giancarlo; Ponzone, Riccardo; Durando, Antonio; Amaducci, Laura; Campadelli, Enrico; Cognetti, Francesco; Frassoldati, Antonio; Michelotti, Andrea; Mura, Silvia; Urracci, Ylenia; Sanna, Giovanni; Gori, Stefania; De Placido, Sabino; Garrone, Ornella; Fabi, Alessandra; Barone, Carla; Tamberi, Stefano; Bighin, Claudia; Puglisi, Fabio; Moretti, Gabriella; Arpino, Grazia; Ballestrero, Alberto; Poggio, Francesca; Lambertini, Matteo; Montemurro, Filippo; Bruzzi, Paolo
Fertility counseling of young breast cancer patients 1-gen-2013 Lambertini, M; Anserini, P; Levaggi, A; Poggio, F; Del Mastro, L
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial 1-gen-2022 Del Mastro, Lucia; Poggio, Francesca; Blondeaux, Eva; De Placido, Sabino; Giuliano, Mario; Forestieri, Valeria; De Laurentiis, Michelino; Gravina, Adriano; Bisagni, Giancarlo; Rimanti, Anita; Turletti, Anna; Nisticò, Cecilia; Vaccaro, Angela; Cognetti, Francesco; Fabi, Alessandra; Gasparro, Simona; Garrone, Ornella; Alicicco, Maria Grazia; Urracci, Ylenia; Mansutti, Mauro; Poletti, Paola; Correale, Pierpaolo; Bighin, Claudia; Puglisi, Fabio; Montemurro, Filippo; Colantuoni, Giuseppe; Lambertini, Matteo; Boni, Luca
Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient–level data 1-gen-2018 Lambertini, Matteo; Moore, Halle C. F.; Leonard, Robert C. F.; Loibl, Sibylle; Munster, Pamela; Bruzzone, Marco; Boni, Luca; Unger, Joseph M.; Anderson, Richard A.; Mehta, Keyur; Minton, Susan; Poggio, Francesca; Albain, Kathy S.; Adamson, Douglas J. A.; Gerber, Bernd; Cripps, Amy; Bertelli, Gianfilippo; Seiler, Sabine; Ceppi, Marcello; Partridge, Ann H.; Del Mastro, Lucia
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials 1-gen-2014 DEL MASTRO, Lucia; Ceppi, M; Poggio, Francesca; Bighin, C; Peccatori, F; Demeestere, I; Levaggi, A; Giraudi, S; Lambertini, Matteo; D'Alonzo, A; Canavese, G; Pronzato, P; Bruzzi, P
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 1-gen-2017 Bighin, Claudia; Dozin, Beatrice; Poggio, Francesca; Ceppi, Marcello; Bruzzi, Paolo; D'Alonzo, Alessia; Levaggi, Alessia; Giraudi, Sara; Lambertini, Matteo; Miglietta, Loredana; Vaglica, Marina; Fontana, Vincenzo; Iacono, Giuseppina; Pronzato, Paolo; Del Mastro, Lucia
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 1-gen-2020 Tagliamento, M.; Spagnolo, F.; Poggio, F.; Soldato, D.; Conte, B.; Ruelle, T.; Barisione, E.; De Maria, A.; Del Mastro, L.; Di Maio, M.; Lambertini, M.